TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21999299

Group type: EXPERIMENTAL
Intervention: Creatine supplementation (5 g·day(‐1))
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 18433494

Group type: EXPERIMENTAL
Intervention: Nurse-led ART
Number of subjects: 12300

Group type: COMPARATOR
Intervention: Doctor-led ART
Number of subjects: 12300
Study: 16604827

Group type: EXPERIMENTAL
Intervention: High molecular weight hyaluronate, treated once weekly for 3 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low molecular weight hyaluronate, treated once weekly for 5 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 14687510

Group type: EXPERIMENTAL
Intervention: nabumetone
Number of subjects: 1732

Group type: EXPERIMENTAL
Intervention: meloxicam
Number of subjects: 1732

Group type: EXPERIMENTAL
Intervention: naproxen
Number of subjects: 1732

Group type: EXPERIMENTAL
Intervention: nimesulide
Number of subjects: 1732

Group type: EXPERIMENTAL
Intervention: ibuprofen
Number of subjects: 1732

Group type: EXPERIMENTAL
Intervention: diclofenac
Number of subjects: 1732

Group type: EXPERIMENTAL
Intervention: oxaprozin
Number of subjects: 1732
Study: 11018608

Group type: EXPERIMENTAL
Intervention: Deflazacort 30 mg daily (max 10 days) plus slow-release nifedipine 30 mg daily (max 4 weeks)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Wait-and-watch approach
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Deflazacort and nifedipine
Number of subjects: 96
Study: 9028151

Group type: EXPERIMENTAL
Intervention: Vitamin E (1200 mg/day)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 1513086

Group type: EXPERIMENTAL
Intervention: Intravenous 1,25 dihydroxycholecalciferol (2 micrograms/m2)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control subjects (no intervention)
Number of subjects: 11
Study: 6148339

Group type: EXPERIMENTAL
Intervention: prazepam (10 mg)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: clorazepate (7.5 mg)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: diazepam (5 mg)
Number of subjects: 31
Study: 31464890

Group type: EXPERIMENTAL
Intervention: Tuina therapy (once daily for 2 days)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tuina therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard medical care
Number of subjects: 0
Study: 28112587

Group type: EXPERIMENTAL
Intervention: Stereoscopic display
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-stereoscopic display
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Video Game Experience (VGE)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Flow state
Number of subjects: 0
Study: 25665674

Group type: EXPERIMENTAL
Intervention: Intra-abdominal instillation of isotonic saline (S)
Number of subjects: 71

Group type: COMPARATOR
Intervention: No saline (NS)
Number of subjects: 71
Study: 24415509

Group type: EXPERIMENTAL
Intervention: Feedback from medical students
Number of subjects: 32

Group type: COMPARATOR
Intervention: No feedback from medical students (Control)
Number of subjects: 32
Study: 22955400

Group type: EXPERIMENTAL
Intervention: Arthroscopic repair
Number of subjects: 60

Group type: COMPARATOR
Intervention: Mini-open repair
Number of subjects: 60
Study: 20926897

Group type: EXPERIMENTAL
Intervention: Hospira filgrastim (5 μg/kg/day)
Number of subjects: 279

Group type: COMPARATOR
Intervention: Amgen filgrastim (5 μg/kg/day)
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: Hospira filgrastim
Number of subjects: 279

Group type: COMPARATOR
Intervention: Amgen filgrastim
Number of subjects: 279
Study: 17685748

Group type: EXPERIMENTAL
Intervention: Bupropion
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Concurrent stimulant treatment
Number of subjects: 57
Study: 15148348

Group type: EXPERIMENTAL
Intervention: STARBRIGHT CD-ROM program
Number of subjects: 47

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 47
Study: 11444452

Group type: EXPERIMENTAL
Intervention: Intrathecal sufentanil 5 microg plus bupivacaine 1.25 mg (Group S)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intrathecal fentanyl 25 microg plus bupivacaine 1.25 mg (Group F)
Number of subjects: 40
Study: 9589832

Group type: EXPERIMENTAL
Intervention: Mesigyna (norethisterone enanthate, 50 mg, and estradiol valerate, 5 mg)
Number of subjects: 357

Group type: EXPERIMENTAL
Intervention: Cyclofem (medroxyprogesterone acetate, 25 mg, and estradiol cypionate, 5 mg)
Number of subjects: 357

Group type: EXPERIMENTAL
Intervention: Both preparations
Number of subjects: 357
Study: 7977884

Group type: EXPERIMENTAL
Intervention: Dialectical behavior therapy
Number of subjects: 26

Group type: COMPARATOR
Intervention: Treatment-as-usual
Number of subjects: 26
Study: 2815168

Group type: EXPERIMENTAL
Intervention: Wet root canal instrumentation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dry root canal instrumentation
Number of subjects: 0
Study: 779926

Group type: EXPERIMENTAL
Intervention: 2-mg nicotine chewing gum
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo gum
Number of subjects: 43

Group type: COMPARATOR
Intervention: Smoking
Number of subjects: 43
Study: 30625169

Group type: EXPERIMENTAL
Intervention: Prototype A1
Number of subjects: 383

Group type: EXPERIMENTAL
Intervention: Prototype A2
Number of subjects: 383

Group type: EXPERIMENTAL
Intervention: Prototype B1
Number of subjects: 383

Group type: EXPERIMENTAL
Intervention: Prototype B2
Number of subjects: 383

Group type: COMPARATOR
Intervention: 3M 1870
Number of subjects: 383

Group type: COMPARATOR
Intervention: 3M 1860
Number of subjects: 383
Study: 28315576

Group type: EXPERIMENTAL
Intervention: Mild-compression knee high diabetic socks (18-25mmHg)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Non-compression knee high diabetic socks
Number of subjects: 80
Study: 25901835

Group type: EXPERIMENTAL
Intervention: Intravitreal ranibizumab
Number of subjects: 881
Study: 22487388

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control (Normal saline)
Number of subjects: 72
Study: 22151988

Group type: EXPERIMENTAL
Intervention: Gemcitabine (1250 mg/m²) and Oxaliplatin (70 mg/m²) given on days 1 and 8 of a 21-day cycle
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Gemcitabine and Oxaliplatin
Number of subjects: 46
Study: 18648228

Group type: EXPERIMENTAL
Intervention: Remifentanil (30 microg.kg.h)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Remifentanil (7.5 microg.kg.h)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 27
Study: 17053267

Group type: EXPERIMENTAL
Intervention: Highly visible CPP display
Number of subjects: 157

Group type: COMPARATOR
Intervention: Control group (no prominent CPP display)
Number of subjects: 157
Study: 12916659

Group type: EXPERIMENTAL
Intervention: Chromoendoscopy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Magnification endoscopy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chromoendoscopy and magnification endoscopy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Methylene blue
Number of subjects: 0
Study: 10852255

Group type: EXPERIMENTAL
Intervention: RA‐1 (ayurvedic plant extract formulation)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 182
Study: 9663829

Group type: EXPERIMENTAL
Intervention: Pentasa 1 g suppository once daily
Number of subjects: 50

Group type: COMPARATOR
Intervention: Claversal 500 mg suppository b.d.
Number of subjects: 50
Study: 8314414

Group type: EXPERIMENTAL
Intervention: Normal glucose tolerance at baseline
Number of subjects: 637

Group type: EXPERIMENTAL
Intervention: Impaired glucose tolerance at baseline
Number of subjects: 637

Group type: EXPERIMENTAL
Intervention: Diabetes at baseline
Number of subjects: 637
Study: 3782627

Group type: EXPERIMENTAL
Intervention: Sucrose (6 ounces of juice)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Artificial sweetener (6 ounces of juice)
Number of subjects: 8
Study: 31302205

Group type: EXPERIMENTAL
Intervention: DAA verification
Number of subjects: 52

Group type: COMPARATOR
Intervention: Regular verification
Number of subjects: 52

Group type: COMPARATOR
Intervention: Independent abstraction
Number of subjects: 52
Study: 28429843

Group type: EXPERIMENTAL
Intervention: Rimonabant 20 mg
Number of subjects: 2097

Group type: EXPERIMENTAL
Intervention: Rimonabant 5 mg
Number of subjects: 2097

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2097
Study: 26503242

Group type: EXPERIMENTAL
Intervention: Altitude training (AT)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (Cg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sea level training (SLT)
Number of subjects: 16
Study: 25137195

Group type: EXPERIMENTAL
Intervention: Ballistic jump technique
Number of subjects: 11

Group type: COMPARATOR
Intervention: Conventional concentric technique
Number of subjects: 11
Study: 22105051

Group type: EXPERIMENTAL
Intervention: Occlusion training (4 weeks, low-intensity resistance training with blood-flow occlusion, 3 times per week)
Number of subjects: 32
Study: 19170450

Group type: EXPERIMENTAL
Intervention: Multidimensional family therapy (MDFT)
Number of subjects: 83
Study: 17762769

Group type: EXPERIMENTAL
Intervention: Internet-based rehabilitation programme (20-week duration, 19 films, written material, internet dialogue)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Waiting-list group (control)
Number of subjects: 60
Study: 16150110

Group type: EXPERIMENTAL
Intervention: Melatonin treatment
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study: 12193522

Group type: EXPERIMENTAL
Intervention: Serum alkaline phosphatase
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Bone mineral content
Number of subjects: 108
Study: 9619619

Group type: EXPERIMENTAL
Intervention: Mechanical valves (St. Jude Medical, Omnicarbon)
Number of subjects: 213
Study: 7659768

Group type: EXPERIMENTAL
Intervention: Nicotine (20 micrograms/kg per presentation) administered by nasal spray every 30 min for 2 h
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Alcohol (0.5 g/kg)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Nicotine plus alcohol
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 2567580

Group type: EXPERIMENTAL
Intervention: 200 mg cimetidine
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 100 mg ranitidine
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 400 mg cimetidine
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study: 1019862

Group type: EXPERIMENTAL
Intervention: Fibrinolytic therapy
Number of subjects: 17

Group type: COMPARATOR
Intervention: Routine anticoagulant therapy
Number of subjects: 17
Study: 30316888

Group type: EXPERIMENTAL
Intervention: Sarilumab 200 mg
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 28655692

Group type: EXPERIMENTAL
Intervention: Linkus Syrup
Number of subjects: 147

Group type: COMPARATOR
Intervention: Acefyllin Piperazine
Number of subjects: 147

Group type: COMPARATOR
Intervention: Aminophylline Diphenhydramine group
Number of subjects: 147
Study: 24841770

Group type: EXPERIMENTAL
Intervention: Live simulation
Number of subjects: 56

Group type: COMPARATOR
Intervention: Virtual reality simulation
Number of subjects: 56

Group type: COMPARATOR
Intervention: Both groups (A and B)
Number of subjects: 56
Study: 23505057

Group type: EXPERIMENTAL
Intervention: Ferric carboxymaltose (FCM)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Iron dextran
Number of subjects: 55
Study: 21596205

Group type: EXPERIMENTAL
Intervention: Stepped collaborative care model integrating care management (posttraumatic concern elicitation and amelioration, motivational interviewing, and behavioral activation) with cognitive behavioral therapy and pharmacotherapy targeting PTSD
Number of subjects: 207
Study: 19164413

Group type: EXPERIMENTAL
Intervention: Conventional method (CM) with 37% phosphoric acid for 30 seconds
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Transbond Plus self-etching primer (SEP)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Machine debonding
Number of subjects: 100

Group type: COMPARATOR
Intervention: Plier debonding
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both groups (CM and SEP)
Number of subjects: 100
Study: 16702196

Group type: EXPERIMENTAL
Intervention: Cigarette advertising and pack displays
Number of subjects: 605

Group type: EXPERIMENTAL
Intervention: Pack displays only
Number of subjects: 605

Group type: COMPARATOR
Intervention: No cigarettes (control group)
Number of subjects: 605

Group type: EXPERIMENTAL
Intervention: Cigarette advertising
Number of subjects: 605
Study: 15243144

Group type: EXPERIMENTAL
Intervention: >65% recovery at 7 days
Number of subjects: 1187

Group type: COMPARATOR
Intervention: <65% recovery at 7 days
Number of subjects: 1187

Group type: EXPERIMENTAL
Intervention: Recovery (per 10% increase)
Number of subjects: 1187
Study: 11902567

Group type: EXPERIMENTAL
Intervention: Transdermal fentanyl
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sustained release morphine formulations
Number of subjects: 0
Study: 8989255

Group type: EXPERIMENTAL
Intervention: Desmopressin alone (10 micrograms)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: CRH alone (100 micrograms)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Desmopressin and CRH combined
Number of subjects: 25

Group type: COMPARATOR
Intervention: CRH alone
Number of subjects: 25

Group type: COMPARATOR
Intervention: Desmopressin alone
Number of subjects: 25

Group type: COMPARATOR
Intervention: Standard CRH test
Number of subjects: 25
Study: 8203418

Group type: EXPERIMENTAL
Intervention: RU 486 (25 mg daily for 3 months)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Leuprolide acetate (3.75 mg monthly for 3 months)
Number of subjects: 14
Study: 3307894

Group type: EXPERIMENTAL
Intervention: Nifedipine 10 mg three times daily for 6 weeks
Number of subjects: 10
Study: 31960058

Group type: EXPERIMENTAL
Intervention: Extended-pulsed fidaxomicin (EPFX) regimen: oral fidaxomicin twice daily for Days 1-5; once daily on alternate days for Days 7-25.
Number of subjects: 14
Study: 30426694

Group type: EXPERIMENTAL
Intervention: 3-month lifestyle intervention (weekly nutrition and health classes, exercise sessions 3 days/week)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: 3-month lifestyle intervention
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: 3-month lifestyle intervention (in a subsample with prediabetes)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Comparison control (received laboratory results and general health information)
Number of subjects: 136
Study: 26586865

Group type: EXPERIMENTAL
Intervention: Group physical therapy (six 1-hour sessions, typically 8 participants per group)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Individual physical therapy (two 1-hour sessions)
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Group physical therapy
Number of subjects: 320

Group type: COMPARATOR
Intervention: Individual physical therapy
Number of subjects: 320
Study: 26594272

Group type: EXPERIMENTAL
Intervention: Ultrasound simulator training
Number of subjects: 93

Group type: COMPARATOR
Intervention: Traditional training method via practice on a human model
Number of subjects: 93
Study: 24395992

Group type: EXPERIMENTAL
Intervention: Intervention providing computers, Internet, and training to low SEP individuals
Number of subjects: 312

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 312
Study: 20406311

Group type: EXPERIMENTAL
Intervention: Behavioral intervention to increase walking
Number of subjects: 572

Group type: EXPERIMENTAL
Intervention: Medical comorbidity
Number of subjects: 572

Group type: EXPERIMENTAL
Intervention: Cognitive function
Number of subjects: 572

Group type: EXPERIMENTAL
Intervention: Physical activity scores
Number of subjects: 572
Study: 17541725

Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stent (SES)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting stent (PES)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Bare-metal stent (BMS)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Tacrolimus-eluting stent (TES)
Number of subjects: 49

Group type: COMPARATOR
Intervention: All stent groups (BMS, SES, PES, TES)
Number of subjects: 49
Study: 15728165

Group type: EXPERIMENTAL
Intervention: Amoxicillin-clavulanate (500 mg/125 mg twice daily)
Number of subjects: 370

Group type: COMPARATOR
Intervention: Ciprofloxacin (250 mg twice daily)
Number of subjects: 370
Study: 14674739

Group type: EXPERIMENTAL
Intervention: Social contextual intervention
Number of subjects: 1717

Group type: COMPARATOR
Intervention: Minimum intervention control condition
Number of subjects: 1717
Study: 10814607

Group type: EXPERIMENTAL
Intervention: High-sodium diet (250 mmol/day)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Low-sodium diet (40 mmol/day)
Number of subjects: 35
Study: 8730163

Group type: COMPARATOR
Intervention: Occlusive glove worn on one hand for 6 h/day for 14 days (Study A)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Occlusive gloves worn on both hands with a cotton glove under the occlusive glove (Study B)
Number of subjects: 37
Study: 1879978

Group type: EXPERIMENTAL
Intervention: Enalapril (2.5 mg)
Number of subjects: 1210

Group type: COMPARATOR
Intervention: Prazosin (0.5 mg)
Number of subjects: 1210
Study: 7147145

Group type: EXPERIMENTAL
Intervention: Maternal medication during labour
Number of subjects: 60

Group type: COMPARATOR
Intervention: No maternal medication during labour
Number of subjects: 60
Study: 30604594

Group type: EXPERIMENTAL
Intervention: Voglibose plus Metformin (vogmet)
Number of subjects: 187

Group type: COMPARATOR
Intervention: Metformin
Number of subjects: 187
Study: 29185490

Group type: EXPERIMENTAL
Intervention: PTSD patients
Number of subjects: 13

Group type: COMPARATOR
Intervention: Trauma-exposed controls
Number of subjects: 13
Study: 26447089

Group type: EXPERIMENTAL
Intervention: SMF (S with fat-containing protein-rich main dishes)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: SMFV (SMF with vegetable dishes)
Number of subjects: 9

Group type: COMPARATOR
Intervention: S (white rice)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: All test meals
Number of subjects: 9
Study: 25501169

Group type: EXPERIMENTAL
Intervention: Intracoronary tirofiban
Number of subjects: 70
Study: 22542748

Group type: EXPERIMENTAL
Intervention: Low dose of aspirin (100 mg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Clopidogrel (75 mg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Low dose of aspirin and clopidogrel (AC)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Low dose of aspirin with clopidogrel and rabeprazole (10 mg) (ACR)
Number of subjects: 20
Study: 19390538

Group type: EXPERIMENTAL
Intervention: 600 mg Allicor daily for 8 weeks
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: 2400 mg Allicor daily
Number of subjects: 84

Group type: COMPARATOR
Intervention: 900 mg Kwai daily
Number of subjects: 84
Study: 17211695

Group type: EXPERIMENTAL
Intervention: Proton pump inhibitor (PPI) therapy, 3-month course, b.i.d.
Number of subjects: 266
Study: 15893086

Group type: EXPERIMENTAL
Intervention: Usual drinking (upper two quartiles)
Number of subjects: 3702

Group type: COMPARATOR
Intervention: Eight or more drinks per occasion
Number of subjects: 3702

Group type: COMPARATOR
Intervention: Alcohol effects in women
Number of subjects: 3702
Study: 16514819

Group type: EXPERIMENTAL
Intervention: Metformin (1500 mg/day)
Number of subjects: 26
Study: 10553837

Group type: EXPERIMENTAL
Intervention: Continuous infusion of 0.125% bupivacaine with sufentanil 0.1 microg/mL and clonidine 1 microg/mL at 10 mL/h
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Continuous infusion of the same solution at 5 mL/h plus PCA boluses (2.5 mL/30 min)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Only PCA boluses (5 mL/30 min) of the same solution
Number of subjects: 60
Study: 8909630

Group type: EXPERIMENTAL
Intervention: Hospital-based violence-prevention consultation intervention
Number of subjects: 180
Study: 1864637

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IVIg) therapy (400 mg/Kg every three weeks for one year)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (saline infusion equivalent volume every three weeks for one year)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IVIg) therapy
Number of subjects: 0
Study: 6750247

Group type: EXPERIMENTAL
Intervention: Prostacyclin (PGI2)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo solution
Number of subjects: 56
Study: 30632852

Group type: EXPERIMENTAL
Intervention: 1% PHMG phosphate irrigation
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: 0.2% chlorhexidine irrigation
Number of subjects: 59

Group type: COMPARATOR
Intervention: Distilled water irrigation
Number of subjects: 59
Study: 29945672

Group type: EXPERIMENTAL
Intervention: Crossbow needle therapy, treatment every other day, three times a week, 20 times in total.
Number of subjects: 306

Group type: COMPARATOR
Intervention: Acupuncture, treatment every other day, three times a week, 20 times in total.
Number of subjects: 306
Study: 26447872

Group type: EXPERIMENTAL
Intervention: ADC values
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: ADC and T2∗ values
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: T1 and T2 values
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: MRI parameters
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Visibility on T1-weighted images
Number of subjects: 28
Study: 24937305

Group type: EXPERIMENTAL
Intervention: Red blood cell (RBC) transfusion
Number of subjects: 20127
Study: 22615015

Group type: EXPERIMENTAL
Intervention: Midazolam 2 mg plus propofol (M+P)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 135
Study: 20530702

Group type: EXPERIMENTAL
Intervention: Intervention arm (psychological intervention)
Number of subjects: 227
Study: 18004123

Group type: EXPERIMENTAL
Intervention: Amoxapine 150 mg/d
Number of subjects: 54

Group type: COMPARATOR
Intervention: Haloperidol 5 mg/d
Number of subjects: 54
Study: 16045553

Group type: EXPERIMENTAL
Intervention: Tamsulosin (0.4 mg daily)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conservative treatment (hydration and tenoxicam)
Number of subjects: 60
Study: 12118650

Group type: EXPERIMENTAL
Intervention: Closure of peritoneum
Number of subjects: 100

Group type: COMPARATOR
Intervention: Non-closure of peritoneum
Number of subjects: 100
Study: 10537960

Group type: EXPERIMENTAL
Intervention: Pharmacoeconomic data from RCTs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Effectiveness studies
Number of subjects: 0